Quick Answer
COGNITION THERAPEUTICS INC reported Earnings Per Share Diluted of $0.32 (loss) per share for the year ending 2025.
- COGNITION THERAPEUTICS INC showed an increase of +62.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from COGNITION THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), COGNITION THERAPEUTICS INC's Earnings Per Share Diluted has grown by 98.7%.
- Historical annual values: Fiscal year 2025: $0.32 (loss) per share | Fiscal year 2024: $0.86 (loss) per share | Fiscal year 2023: $0.86 (loss) per share | Fiscal year 2022: $0.91 (loss) per share | Fiscal year 2021: $3.13 (loss) per share | Fiscal year 2020: $23.76 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: